Reginald Genechten - Biocartis Group Head Chain
Insider
Reginald Genechten is Head Chain of Biocartis Group NV
| Age | 57 |
| Phone | 32 1 563 20 00 |
| Web | https://www.biocartis.com |
Biocartis Group Management Efficiency
The company has return on total asset (ROA) of (0.2245) % which means that it has lost $0.2245 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (48.8364) %, meaning that it generated substantial loss on money invested by shareholders. Biocartis Group's management efficiency ratios could be used to measure how well Biocartis Group manages its routine affairs as well as how well it operates its assets and liabilities.Biocartis Group NV has accumulated 128.15 M in total debt with debt to equity ratio (D/E) of 40.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Biocartis Group NV has a current ratio of 2.76, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Biocartis Group until it has trouble settling it off, either with new capital or with free cash flow. So, Biocartis Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biocartis Group NV sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biocartis to invest in growth at high rates of return. When we think about Biocartis Group's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Arjen MSc | Argen X | 38 | |
| BME MBA | Celyad SA | 66 | |
| David Georges | Celyad SA | N/A | |
| Hannes Iserentant | Celyad SA | N/A | |
| Stephen Rubino | Celyad SA | N/A | |
| Beth DelGiacco | Argen X | N/A | |
| Karl Gubitz | Argen X | 53 | |
| Andria Wilk | Argen X | 49 | |
| Frdric Lehmann | Celyad SA | 59 | |
| David MD | Argen X | 71 | |
| Pr Ir | Argen X | 63 | |
| Malini Moorthy | Argen X | 53 | |
| Philip Ludwig | Ontex Group NV | N/A | |
| An Phan | Celyad SA | N/A | |
| Peter Vanneste | Ontex Group NV | N/A | |
| Gustavo Paz | Ontex Group NV | 61 | |
| Gaelle Vilatte | Ontex Group NV | N/A | |
| EMBA MBA | Argen X | 50 | |
| Marina UdierBlagovic | Celyad SA | N/A | |
| Jonas Deroo | Ontex Group NV | N/A | |
| Stephanie McDonald | Ontex Group NV | N/A | |
Management Performance
| Return On Equity | -48.84 | |||
| Return On Asset | -0.22 |
Biocartis Group NV Leadership Team
Elected by the shareholders, the Biocartis Group's board of directors comprises two types of representatives: Biocartis Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biocartis. The board's role is to monitor Biocartis Group's management team and ensure that shareholders' interests are well served. Biocartis Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biocartis Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Reginald Genechten, Head Chain | ||
| Benoit Devogelaere, Chief Officer | ||
| Erwin Sablon, Head Management | ||
| Geert Maertens, Chairman Officer | ||
| JeanMarc Roelandt, Chief Officer | ||
| Piet Houwen, Chief Officer | ||
| Renate Degrave, Head Communications | ||
| Herman Verrelst, CEO Director | ||
| Dirk Zimmermann, Global Partnering | ||
| Susy Spruyt, Head Organization |
Biocartis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biocartis Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -48.84 | |||
| Return On Asset | -0.22 | |||
| Profit Margin | (1.07) % | |||
| Operating Margin | (0.85) % | |||
| Current Valuation | 182.31 M | |||
| Shares Outstanding | 93.1 M | |||
| Shares Owned By Insiders | 6.66 % | |||
| Shares Owned By Institutions | 27.71 % | |||
| Price To Earning | (9.91) X | |||
| Price To Book | 6.47 X |
Other Information on Investing in Biocartis Stock
Biocartis Group financial ratios help investors to determine whether Biocartis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biocartis with respect to the benefits of owning Biocartis Group security.